Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise

dc.contributor.authorAydin S.Z.
dc.contributor.authorDireskeneli H.
dc.contributor.authorMerkel P.A.
dc.contributor.authorToloza S.
dc.contributor.authorBlockmans D.
dc.contributor.authorSato E.I.
dc.contributor.authorDe Souza A.W.S.
dc.contributor.authorCabral D.
dc.contributor.authorCarette S.
dc.contributor.authorFamorca L.
dc.contributor.authorKhalidi N.
dc.contributor.authorMilman N.
dc.contributor.authorYacyshyn E.
dc.contributor.authorTesar V.
dc.contributor.authorBaslund B.
dc.contributor.authorFaurschou M.
dc.contributor.authorGuillevin L.
dc.contributor.authorPuéchal X.
dc.contributor.authorAries P.
dc.contributor.authorHellmich B.
dc.contributor.authorHerlyn K.
dc.contributor.authorHolle J.
dc.contributor.authorLamprecht P.
dc.contributor.authorMoosig F.
dc.contributor.authorNeumann T.
dc.contributor.authorZwerina J.
dc.contributor.authorTómasson G.
dc.contributor.authorBambery P.
dc.contributor.authorJois R.
dc.contributor.authorRajasekhar L.
dc.contributor.authorSharma A.
dc.contributor.authorSivakumar R.
dc.contributor.authorMolloy E.
dc.contributor.authorHashkes P.
dc.contributor.authorCatapano F.
dc.contributor.authorCimino L.
dc.contributor.authorDe Fanti A.
dc.contributor.authorPipitone N.
dc.contributor.authorSalvarani C.
dc.contributor.authorVaglio A.
dc.contributor.authorKobayashi S.
dc.contributor.authorSuzuki K.
dc.contributor.authorFlores-Suárez L.F.
dc.contributor.authorHinojosa-Azaola A.
dc.contributor.authorBrouwer E.
dc.contributor.authorRutgers A.
dc.contributor.authorStegeman C.
dc.contributor.authorSuppiah R.
dc.contributor.authorHollan I.
dc.contributor.authorArguis P.
dc.contributor.authorCid M.C.
dc.contributor.authorDaikeler T.
dc.contributor.authorAlibaz-Oner F.
dc.contributor.authorHamuryudan V.
dc.contributor.authorHatemi G.
dc.contributor.authorHazirolan T.
dc.contributor.authorInanc M.
dc.contributor.authorKalayci M.B.
dc.contributor.authorKamali S.
dc.contributor.authorKansu T.
dc.contributor.authorKaraaslan Y.
dc.contributor.authorKaradag O.
dc.contributor.authorKeser G.
dc.contributor.authorOnat A.M.
dc.contributor.authorOzbalkan Z.
dc.contributor.authorOzen S.
dc.contributor.authorOzer H.T.E.
dc.contributor.authorPamuk Ö.N.
dc.contributor.authorYilmaz S.G.
dc.contributor.authorBasu N.
dc.contributor.authorCasian A.
dc.contributor.authorChakravarty K.
dc.contributor.authorD'Cruz D.
dc.contributor.authorEdelsten C.
dc.contributor.authorHarper L.
dc.contributor.authorJayne D.
dc.contributor.authorLevy J.
dc.contributor.authorMason J.
dc.contributor.authorRobson J.
dc.contributor.authorScott D.
dc.contributor.authorStanford M.
dc.contributor.authorWatts R.
dc.contributor.authorAlbert D.
dc.contributor.authorAmudala N.
dc.contributor.authorBeckman J.
dc.contributor.authorChacko B.
dc.contributor.authorChung S.
dc.contributor.authorFessler B.
dc.contributor.authorGiardino A.
dc.contributor.authorGrayson P.
dc.contributor.authorHunder G.
dc.contributor.authorLangford C.
dc.contributor.authorLerman M.
dc.contributor.authorLiang K.
dc.contributor.authorLitt H.
dc.contributor.authorMason T.
dc.contributor.authorMatteson E.
dc.contributor.authorMikdashi J.
dc.contributor.authorMohler E.
dc.contributor.authorMonach P.
dc.contributor.authorRice B.
dc.contributor.authorSharma A.
dc.contributor.authorSreih A.
dc.contributor.authorStone J.
dc.contributor.authorTsapatsaris N.
dc.contributor.authorVilla-Forte A.
dc.contributor.authorWarrington K.
dc.contributor.authorYazici Y.
dc.contributor.authorYtterberg S.
dc.date.accessioned2019-10-26T21:16:05Z
dc.date.available2019-10-26T21:16:05Z
dc.date.issued2017
dc.departmentEge Üniversitesien_US
dc.description.abstractObjective. To arrive at consensus for candidate outcomes for disease activity assessment in largevessel vasculitis (LVV) in clinical trials. Methods.A Delphi survey including 99 items was circulated among international experts for 3 rounds. Results. Fifty-seven items were accepted for both giant cell arteritis and Takayasu arteritis. Sixty-seven percent of experts voted to have a common approach for both diseases with additional disease-specific items such as weight loss, scalp tenderness/necrosis, morning stiffness, dizziness, visual symptoms, and imaging. Conclusion. This study highlights similarities and differences in experts' perspectives for assessing clinical activity in LVV and may guide a consensus-driven core set of validated outcomes. Copyright © 2017. All rights reserved.en_US
dc.description.sponsorshipNational Institute of Arthritis and Musculoskeletal and Skin Diseases: U01 AR51874 04, U54 AR057319 National Center for Research Resources: U54 RR019497en_US
dc.description.sponsorshipSponsored by the Vasculitis Clinical Research Consortium, which has received support from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54 AR057319 and U01 AR51874 04), the National Center for Research Resources (U54 RR019497), and the Office of Rare Diseases Research. Additional support for the work of the OMERACT Vasculitis Working Group was received through a Patient-Centered Outcomes Research Institute Pilot Project Grant. S.Z. Aydin, MD, Associate Professor, Division of Rheumatology, The Ottawa Hospital Research Institute, University of Ottawa; H. Direskeneli, MD, Professor of Rheumatology, Division of Rheumatology, Marmara University Faculty of Medicine; P.A. Merkel, MD, MPH, Professor of Medicine and Epidemiology, Division of Rheumatology, and Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania. Address correspondence to Dr. P.A. Merkel, Section of Rheumatology, University of Pennsylvania, White Building, 5th Floor Penn, 3400 Spruce St., Philadelphia, Pennsylvania 19104, USA. E-mail: pmerkel@upenn.edu Accepted for publication June 3, 2017. --en_US
dc.identifier.doi10.3899/jrheum.161269en_US
dc.identifier.endpage1932en_US
dc.identifier.issn0315-162X
dc.identifier.issue12en_US
dc.identifier.pmid28864648en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1928en_US
dc.identifier.urihttps://doi.org/10.3899/jrheum.161269
dc.identifier.urihttps://hdl.handle.net/11454/16144
dc.identifier.volume44en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherJournal of Rheumatologyen_US
dc.relation.ispartofJournal of Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGiant cell arteritisen_US
dc.subjectLarge vesselen_US
dc.subjectOutcomesen_US
dc.subjectTakayasu arteritisen_US
dc.subjectVasculitisen_US
dc.titleAssessment of disease activity in large-vessel vasculitis: Results of an international delphi exerciseen_US
dc.typeArticleen_US

Dosyalar